Home 2023

Hepatitis B

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Alex Philippidis -
0
And Then There Were Four: VBI Scores First FDA Approval with Hepatitis B Vaccine
Coronavirus

And Then There Were Four: VBI Scores First FDA Approval with Hepatitis B Vaccine

Alex Philippidis -
0
NIH Blood Test Developed for Liver Cancer Screening
Cancer

NIH Blood Test Developed for Liver Cancer Screening

John Sterling -
0
University of Queensland (UQ), CEPI, CSL Behring and Dynavax – UQ-CSL V451
News

University of Queensland (UQ), CEPI, CSL Behring and Dynavax – UQ-CSL V451

Alex Philippidis -
0
Roche, Dicerna Launch Up-to-$1.67B Hepatitis B Collaboration
GEN Edge

Roche, Dicerna Launch Up-to-$1.67B Hepatitis B Collaboration

Alex Philippidis -
0
$20 Blood Test Could Contribute to “Global HBV Elimination”
Infectious Diseases

$20 Blood Test Could Contribute to “Global HBV Elimination”

GEN Staff Writer -
1
Hepatitis B Monoclonal Antibodies
New Products

Hepatitis B Monoclonal Antibodies

GEN Staff Writer -
0
RNAi Therapeutics: To the Liver … and Beyond
Insights

RNAi Therapeutics: To the Liver … and Beyond

William Iannuccilli -
0
Hepatitis B Infects Organ-on-a-Chip Platform
Drug Discovery

Hepatitis B Infects Organ-on-a-Chip Platform

GEN Staff Writer -
0
The Prodrug Opportunity: Making Good Drugs Better
Insights

The Prodrug Opportunity: Making Good Drugs Better

Travis Mickle -
1
123...6Page 1 of 6
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.